1246 related articles for article (PubMed ID: 28370526)
1. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.
Orban M; Orban M; Lesevic H; Braun D; Deseive S; Sonne C; Hutterer L; Grebmer C; Khandoga A; Pache J; Mehilli J; Schunkert H; Kastrati A; Hagl C; Bauer A; Massberg S; Boekstegers P; Nabauer M; Ott I; Hausleiter J
J Interv Cardiol; 2017 Jun; 30(3):226-233. PubMed ID: 28370526
[TBL] [Abstract][Full Text] [Related]
2. Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation.
Keßler M; Seeger J; Muche R; Wöhrle J; Rottbauer W; Markovic S
Eur J Heart Fail; 2019 Feb; 21(2):182-192. PubMed ID: 30178493
[TBL] [Abstract][Full Text] [Related]
3. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
Muller DWM; Sorajja P; Duncan A; Bethea B; Dahle G; Grayburn P; Babaliaros V; Guerrero M; Thourani VH; Bedogni F; Denti P; Dumonteil N; Modine T; Jansz P; Chuang ML; Blanke P; Leipsic J; Badhwar V
J Am Coll Cardiol; 2021 Nov; 78(19):1847-1859. PubMed ID: 34736561
[TBL] [Abstract][Full Text] [Related]
4. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
[TBL] [Abstract][Full Text] [Related]
5. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
[TBL] [Abstract][Full Text] [Related]
6. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.
Lim DS; Reynolds MR; Feldman T; Kar S; Herrmann HC; Wang A; Whitlow PL; Gray WA; Grayburn P; Mack MJ; Glower DD
J Am Coll Cardiol; 2014 Jul; 64(2):182-92. PubMed ID: 24184254
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.
Triantafyllis AS; Kortlandt F; Bakker AL; Swaans MJ; Eefting FD; van der Heyden JA; Post MC; Rensing BW
Catheter Cardiovasc Interv; 2016 Feb; 87(3):467-75. PubMed ID: 26268819
[TBL] [Abstract][Full Text] [Related]
8. 2-Year Outcomes After Transcatheter Mitral Valve Replacement.
Regueiro A; Ye J; Fam N; Bapat VN; Dagenais F; Peterson MD; Windecker S; Webb JG; Rodés-Cabau J
JACC Cardiovasc Interv; 2017 Aug; 10(16):1671-1678. PubMed ID: 28838478
[TBL] [Abstract][Full Text] [Related]
9. Early Experience With New Transcatheter Mitral Valve Replacement.
Bapat V; Rajagopal V; Meduri C; Farivar RS; Walton A; Duffy SJ; Gooley R; Almeida A; Reardon MJ; Kleiman NS; Spargias K; Pattakos S; Ng MK; Wilson M; Adams DH; Leon M; Mack MJ; Chenoweth S; Sorajja P;
J Am Coll Cardiol; 2018 Jan; 71(1):12-21. PubMed ID: 29102689
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Transcatheter Mitral Valve Replacement: First-in-Human Experience With a New Transseptal System.
Webb JG; Murdoch DJ; Boone RH; Moss R; Attinger-Toller A; Blanke P; Cheung A; Hensey M; Leipsic J; Ong K; Sathananthan J; Wood DA; Ye J; Tartara P
J Am Coll Cardiol; 2019 Mar; 73(11):1239-1246. PubMed ID: 30898198
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous edge-to-edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation.
Braun D; Lesevic H; Orban M; Michalk F; Barthel P; Hoppe K; Sonne C; Pache J; Mehilli J; Kastrati A; Hausleiter J; Massberg S
Catheter Cardiovasc Interv; 2014 Jul; 84(1):137-46. PubMed ID: 24323541
[TBL] [Abstract][Full Text] [Related]
12. Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinical and echocardiographic results.
De Bonis M; Lapenna E; Taramasso M; La Canna G; Buzzatti N; Pappalardo F; Alfieri O
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2027-32. PubMed ID: 24755329
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.
Alozie A; Paranskaya L; Westphal B; Kaminski A; Sherif M; Sindt M; Kische S; Schubert J; Diedrich D; Ince H; Steinhoff G; Öner A
BMC Cardiovasc Disord; 2017 Mar; 17(1):85. PubMed ID: 28320316
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.
Kitamura M; Kaneko H; Schlüter M; Schewel D; Schmidt T; Alessandrini H; Kreidel F; Neuss M; Butter C; Kuck KH; Frerker C
Clin Res Cardiol; 2019 Mar; 108(3):264-272. PubMed ID: 30097683
[TBL] [Abstract][Full Text] [Related]
15. The MitraClip Procedure in Patients With Moderate Resting but Severe Exercise-Induced Mitral Regurgitation.
Curio J; Tarar W; Al-Hindwan HSA; Neumann R; Berger C; Hoting MO; Kasner M; Lendlein A; Landmesser U; Reinthaler M
J Invasive Cardiol; 2020 Jan; 32(1):E1-E8. PubMed ID: 31893503
[TBL] [Abstract][Full Text] [Related]
16. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
[TBL] [Abstract][Full Text] [Related]
17. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes.
Conradi L; Treede H; Rudolph V; Graumüller P; Lubos E; Baldus S; Blankenberg S; Reichenspurner H
Eur J Cardiothorac Surg; 2013 Sep; 44(3):490-6; discussion 496. PubMed ID: 23401496
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial.
McCarthy PM; Whisenant B; Asgar AW; Ailawadi G; Hermiller J; Williams M; Morse A; Rinaldi M; Grayburn P; Thomas JD; Martin R; Asch FM; Shu Y; Sundareswaran K; Moat N; Kar S
J Am Heart Assoc; 2023 Feb; 12(4):e027504. PubMed ID: 36752231
[TBL] [Abstract][Full Text] [Related]
19. MitraClip implantation for high risk patients with severe mitral regurgitation: the Sheba experience.
Koifman E; Fefer P; Hay I; Feinberg M; Maor E; Guetta V
Isr Med Assoc J; 2014 Feb; 16(2):91-5. PubMed ID: 24645227
[TBL] [Abstract][Full Text] [Related]
20. Identification of Subclinical Myocardial Dysfunction and Association with Survival after Transcatheter Mitral Valve Repair.
Fukui M; Niikura H; Sorajja P; Hashimoto G; Bae R; Garcia S; Gössl M; Cavalcante JL
J Am Soc Echocardiogr; 2020 Dec; 33(12):1474-1480. PubMed ID: 32919854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
